[S02DA03, antipyrine, The risk or severity of methemoglobinemia can be increased when Zopiclone is combined with Antipyrine.]
[M03AB01, succinylcholine, The risk or severity of adverse effects can be increased when Succinylcholine is combined with Zopiclone.]
[J01EC02, sulfadiazine, The risk or severity of methemoglobinemia can be increased when Sulfadiazine is combined with Zopiclone.]
[S01AB01, sulfamethizole, The metabolism of Zopiclone can be decreased when combined with Sulfamethizole.]
[J01EC01, sulfamethoxazole, The metabolism of Zopiclone can be decreased when combined with Sulfamethoxazole.]
[J01EC03, sulfamoxole, The metabolism of Zopiclone can be decreased when combined with Sulfamoxole.]
[J01EB04, sulfapyridine, The risk or severity of methemoglobinemia can be increased when Sulfapyridine is combined with Zopiclone.]
[M04AB02, sulfinpyrazone, The metabolism of Zopiclone can be decreased when combined with Sulfinpyrazone.]
[S01AB02, sulfisoxazole, The metabolism of Zopiclone can be decreased when combined with Sulfisoxazole.]
[N05AL01, sulpiride, The risk or severity of adverse effects can be increased when Sulpiride is combined with Zopiclone.]
[N03AX03, sulthiame, The risk or severity of adverse effects can be increased when Sulthiame is combined with Zopiclone.]
[A10BB04, glibornuride, The metabolism of Glibornuride can be decreased when combined with Zopiclone.]
[L02BA01, tamoxifen, The metabolism of Zopiclone can be decreased when combined with Tamoxifen.]
[N05CD07, temazepam, The risk or severity of adverse effects can be increased when Temazepam is combined with Zopiclone.]
[L01CB02, teniposide, The metabolism of Zopiclone can be decreased when combined with Teniposide.]
[G03BA03, testosterone, The metabolism of Zopiclone can be decreased when combined with Testosterone.]
[N07XX06, tetrabenazine, The risk or severity of sedation and somnolence can be increased when Zopiclone is combined with Tetrabenazine.]
[S01HA03, tetracaine, The risk or severity of adverse effects can be increased when Tetracaine is combined with Zopiclone.]
[S03AA02, tetracycline, The metabolism of Zopiclone can be decreased when combined with Tetracycline.]
[N05AE05, lurasidone, The risk or severity of adverse effects can be increased when Lurasidone is combined with Zopiclone.]
[A04AD10, dronabinol, Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.]
[N04BC07, apomorphine, The risk or severity of adverse effects can be increased when Apomorphine is combined with Zopiclone.]
[L04AX02, thalidomide, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.]
[R03DA04, theophylline, The metabolism of Zopiclone can be decreased when combined with Theophylline.]
[R06AD03, thiethylperazine, The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Zopiclone.]
[N05CA19, thiopental, The metabolism of Zopiclone can be decreased when combined with Thiopental.]
[N05AB08, thioproperazine, The risk or severity of adverse effects can be increased when Thioproperazine is combined with Zopiclone.]
[N05AC02, thioridazine, The risk or severity of adverse effects can be increased when Thioridazine is combined with Zopiclone.]
[N05AF04, thiothixene, The risk or severity of adverse effects can be increased when Thiothixene is combined with Zopiclone.]
[N05AL03, tiapride, The risk or severity of adverse effects can be increased when Tiapride is combined with Zopiclone.]
[B01AC05, ticlopidine, The metabolism of Zopiclone can be decreased when combined with Ticlopidine.]
[N02AX01, tilidine, The risk or severity of adverse effects can be increased when Tilidine is combined with Zopiclone.]
[A10BB05, tolazamide, The metabolism of Zopiclone can be decreased when combined with Tolazamide.]
[V04CA01, tolbutamide, The metabolism of Zopiclone can be decreased when combined with Tolbutamide.]
[M03BX04, tolperisone, The risk or severity of adverse effects can be increased when Tolperisone is combined with Zopiclone.]
[N02AX02, tramadol, The risk or severity of CNS depression can be increased when Zopiclone is combined with Tramadol.]
[N06AF04, tranylcypromine, The metabolism of Zopiclone can be decreased when combined with Tranylcypromine.]
[N06AX05, trazodone, The risk or severity of adverse effects can be increased when Zopiclone is combined with Trazodone.]
[L01XF01, tretinoin, The metabolism of Zopiclone can be decreased when combined with Tretinoin.]
[N05CD05, triazolam, The risk or severity of adverse effects can be increased when Triazolam is combined with Zopiclone.]
[A03AB12, mepenzolate, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Mepenzolate.]
[N05AB06, trifluoperazine, The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Zopiclone.]
[N05AD02, trifluperidol, The risk or severity of adverse effects can be increased when Trifluperidol is combined with Zopiclone.]
[N05AA05, triflupromazine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Triflupromazine.]
[N04AA01, trihexyphenidyl, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Trihexyphenidyl.]
[R03BA07, mometasone, The metabolism of Zopiclone can be decreased when combined with Mometasone.]
[A03AA05, trimebutine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Trimebutine.]
[R06AD01, trimeprazine, The risk or severity of adverse effects can be increased when Alimemazine is combined with Zopiclone.]
[N03AC02, trimethadione, The risk or severity of adverse effects can be increased when Trimethadione is combined with Zopiclone.]
[J01EA01, trimethoprim, The metabolism of Zopiclone can be decreased when combined with Trimethoprim.]
[N06AA06, trimipramine, The risk or severity of adverse effects can be increased when Trimipramine is combined with Zopiclone.]
[R06AX07, triprolidine, The risk or severity of adverse effects can be increased when Triprolidine is combined with Zopiclone.]
[A03BB01, butylscopolamine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Butylscopolamine.]
[J01FA08, troleandomycin, The metabolism of Zopiclone can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The risk or severity of adverse effects can be increased when Vilazodone is combined with Zopiclone.]
[N06AX02, tryptophan, The risk or severity of adverse effects can be increased when Tryptophan is combined with Zopiclone.]
[M03AA02, tubocurarine, The risk or severity of adverse effects can be increased when Tubocurarine is combined with Zopiclone.]
[L02BX03, abiraterone, The metabolism of Zopiclone can be decreased when combined with Abiraterone.]
[A10BH05, linagliptin, The metabolism of Zopiclone can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Zopiclone can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Zopiclone can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Zopiclone can be decreased when combined with Rilpivirine.]
[N03AX21, ezogabine, The risk or severity of adverse effects can be increased when Ezogabine is combined with Zopiclone.]
[B01AC24, ticagrelor, The metabolism of Zopiclone can be decreased when combined with Ticagrelor.]
[C08DA01, verapamil, The metabolism of Zopiclone can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Zopiclone can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Zopiclone can be decreased when combined with Vinblastine.]
[B01AA03, warfarin, The metabolism of Zopiclone can be increased when combined with Warfarin.]
[J05AF01, zidovudine, The metabolism of Zopiclone can be decreased when combined with Zidovudine.]
[N05AF05, zuclopenthixol, The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Zopiclone.]
[J05AE02, indinavir, The metabolism of Zopiclone can be decreased when combined with Indinavir.]
[N03AX14, levetiracetam, The risk or severity of adverse effects can be increased when Levetiracetam is combined with Zopiclone.]
[L01EC01, vemurafenib, The metabolism of Zopiclone can be decreased when combined with Vemurafenib.]
[L01FX05, brentuximab vedotin, The metabolism of Zopiclone can be decreased when combined with Brentuximab vedotin.]
[L01ED01, crizotinib, The metabolism of Zopiclone can be decreased when combined with Crizotinib.]
[R03DC01, zafirlukast, The metabolism of Zopiclone can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, The metabolism of Zopiclone can be decreased when combined with Rabeprazole.]
[N05AE04, ziprasidone, The risk or severity of adverse effects can be increased when Zopiclone is combined with Ziprasidone.]
[N02BA01, aspirin, The metabolism of Zopiclone can be decreased when combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Zopiclone.]
[G04BD07, tolterodine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Tolterodine.]
[J02AC03, voriconazole, The metabolism of Zopiclone can be decreased when combined with Voriconazole.]
[M03AC04, atracurium, The risk or severity of adverse effects can be increased when Atracurium is combined with Zopiclone.]
[S01FA01, atropine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Atropine.]
[L01XJ01, vismodegib, The metabolism of Vismodegib can be decreased when combined with Zopiclone.]
[R07AX02, ivacaftor, The metabolism of Zopiclone can be decreased when combined with Ivacaftor.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Zopiclone.]
[M03BX01, baclofen, Baclofen may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.]
[A08AA11, lorcaserin, The risk or severity of adverse effects can be increased when Lorcaserin is combined with Zopiclone.]
[V03AX03, cobicistat, The metabolism of Zopiclone can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Zopiclone can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Zopiclone can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The metabolism of Zopiclone can be decreased when combined with Bosutinib.]
[L04AA31, teriflunomide, The metabolism of Zopiclone can be decreased when combined with Teriflunomide.]
[L01EX05, regorafenib, The metabolism of Zopiclone can be decreased when combined with Regorafenib.]
[N05CA04, barbital, The risk or severity of adverse effects can be increased when Barbital is combined with Zopiclone.]
[J05AE04, nelfinavir, The metabolism of Zopiclone can be decreased when combined with Nelfinavir.]
[S01GA07, brimonidine, Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.]
[N04BD02, rasagiline, The risk or severity of adverse effects can be increased when Rasagiline is combined with Zopiclone.]
[A03FA09, mosapride, The risk or severity of adverse effects can be increased when Mosapride is combined with Zopiclone.]
[N06DA02, donepezil, The risk or severity of adverse effects can be increased when Donepezil is combined with Zopiclone.]
[N03AX22, perampanel, Perampanel may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.]
[N02CC03, zolmitriptan, The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Zopiclone.]
[R06AC06, thonzylamine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Thonzylamine.]
[G04BD10, darifenacin, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Darifenacin.]
[N01AA01, ethyl ether, The risk or severity of adverse effects can be increased when Diethyl ether is combined with Zopiclone.]
[L01EX07, cabozantinib, The metabolism of Zopiclone can be decreased when combined with Cabozantinib.]
[H01CB05, pasireotide, The metabolism of Zopiclone can be decreased when combined with Pasireotide.]
[G04BE03, sildenafil, The metabolism of Zopiclone can be decreased when combined with Sildenafil.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Zopiclone.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Zopiclone.]
[C10AX12, lomitapide, The metabolism of Zopiclone can be decreased when combined with Lomitapide.]
[L04AX06, pomalidomide, The risk or severity of adverse effects can be increased when Pomalidomide is combined with Zopiclone.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be decreased when combined with Zopiclone.]
[N05AD07, benperidol, The risk or severity of adverse effects can be increased when Benperidol is combined with Zopiclone.]
[M04AB03, benzbromarone, The metabolism of Zopiclone can be decreased when combined with Benzbromarone.]
[A06AX06, tegaserod, The metabolism of Zopiclone can be decreased when combined with Tegaserod.]
[R02AD01, benzocaine, The risk or severity of adverse effects can be increased when Benzocaine is combined with Zopiclone.]
[M01AH01, celecoxib, The risk or severity of methemoglobinemia can be increased when Celecoxib is combined with Zopiclone.]
[N02CC02, naratriptan, The risk or severity of adverse effects can be increased when Naratriptan is combined with Zopiclone.]
[L04AA18, everolimus, The metabolism of Zopiclone can be decreased when combined with Everolimus.]
[N04AC01, benztropine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Benzatropine.]
[L01EC02, dabrafenib, The serum concentration of Zopiclone can be decreased when it is combined with Dabrafenib.]
[L01EE01, trametinib, The metabolism of Zopiclone can be decreased when combined with Trametinib.]
[P03AX06, benzyl alcohol, The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Zopiclone.]
[N06AX28, levomilnacipran, The risk or severity of adverse effects can be increased when Zopiclone is combined with Levomilnacipran.]
[C02KX05, riociguat, The metabolism of Riociguat can be decreased when combined with Zopiclone.]
[N06AX26, vortioxetine, The risk or severity of adverse effects can be increased when Vortioxetine is combined with Zopiclone.]
[N03AF04, eslicarbazepine, The risk or severity of adverse effects can be increased when Eslicarbazepine is combined with Zopiclone.]
[J05AP05, simeprevir, The metabolism of Zopiclone can be decreased when combined with Simeprevir.]
[N03AG04, vigabatrin, The risk or severity of adverse effects can be increased when Vigabatrin is combined with Zopiclone.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Zopiclone.]
[N05CH03, tasimelteon, The risk or severity of adverse effects can be increased when Tasimelteon is combined with Zopiclone.]
[A16AA07, metreleptin, The metabolism of Zopiclone can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Zopiclone can be increased when combined with Apremilast.]
[S03BA03, betamethasone, The metabolism of Zopiclone can be increased when combined with Betamethasone.]
[C10AB02, bezafibrate, The metabolism of Zopiclone can be decreased when combined with Bezafibrate.]
[L04AC11, siltuximab, The metabolism of Zopiclone can be decreased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Zopiclone can be decreased when combined with Ceritinib.]
[A03BA03, hyoscyamine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Hyoscyamine.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Zopiclone.]
[L01EM01, idelalisib, The metabolism of Zopiclone can be decreased when combined with Idelalisib.]
[N01AX05, alfaxalone, The risk or severity of adverse effects can be increased when Alfaxalone is combined with Zopiclone.]
[R03AC19, olodaterol, The metabolism of Olodaterol can be decreased when combined with Zopiclone.]
[D11AA01, glycopyrronium, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Glycopyrronium.]
[N05CM19, suvorexant, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.]
[J01XA05, oritavancin, The metabolism of Zopiclone can be decreased when combined with Oritavancin.]
[N05AA04, acepromazine, The risk or severity of adverse effects can be increased when Acepromazine is combined with Zopiclone.]
[N04AA02, biperiden, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Biperiden.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Zopiclone.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Zopiclone.]
[L01XK01, olaparib, The metabolism of Zopiclone can be decreased when combined with Olaparib.]
[B01AA01, dicumarol, The metabolism of Zopiclone can be decreased when combined with Dicoumarol.]
[N06AX11, mirtazapine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Zopiclone can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Zopiclone can be decreased when combined with Palbociclib.]
[N02BE01, acetaminophen, The metabolism of Zopiclone can be decreased when combined with Acetaminophen.]
[A03AA09, difemerine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Difemerine.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Zopiclone.]
[N05AX16, brexpiprazole, The risk or severity of adverse effects can be increased when Brexpiprazole is combined with Zopiclone.]
[G02CX02, flibanserin, The risk or severity of adverse effects can be increased when Flibanserin is combined with Zopiclone.]
[N05AX15, cariprazine, The risk or severity of adverse effects can be increased when Cariprazine is combined with Zopiclone.]
[S01EC01, acetazolamide, The metabolism of Zopiclone can be decreased when combined with Acetazolamide.]
[N05AB07, acetophenazine, The risk or severity of adverse effects can be increased when Acetophenazine is combined with Zopiclone.]
[A02BC03, lansoprazole, The metabolism of Zopiclone can be decreased when combined with Lansoprazole.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Zopiclone.]
[J02AC05, isavuconazole, The metabolism of Zopiclone can be decreased when combined with Isavuconazole.]
[B01AC27, selexipag, The metabolism of Selexipag can be decreased when combined with Zopiclone.]
[A10BB31, acetohexamide, The metabolism of Zopiclone can be decreased when combined with Acetohexamide.]
[M04AB05, lesinurad, The metabolism of Lesinurad can be decreased when combined with Zopiclone.]
[J05AP10, elbasvir, The metabolism of Zopiclone can be decreased when combined with Elbasvir.]
[N05CA05, aprobarbital, The risk or severity of adverse effects can be increased when Aprobarbital is combined with Zopiclone.]
[N03AX23, brivaracetam, The risk or severity of adverse effects can be increased when Brivaracetam is combined with Zopiclone.]
[L01XX52, venetoclax, The metabolism of Zopiclone can be decreased when combined with Venetoclax.]
[N05BA08, bromazepam, The risk or severity of adverse effects can be increased when Bromazepam is combined with Zopiclone.]
[N04BC01, bromocriptine, The metabolism of Zopiclone can be decreased when combined with Bromocriptine.]
[A03AX08, alverine, The risk or severity of adverse effects can be increased when Alverine is combined with Zopiclone.]
[R06AB01, brompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Zopiclone.]
[N06AA19, amineptin, The risk or severity of adverse effects can be increased when Amineptine is combined with Zopiclone.]
[N06BX11, aniracetam, The risk or severity of adverse effects can be increased when Aniracetam is combined with Zopiclone.]
[N01BB01, bupivacaine, The risk or severity of adverse effects can be increased when Bupivacaine is combined with Zopiclone.]
[N07BC01, buprenorphine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.]
[N05BE01, buspirone, The risk or severity of adverse effects can be increased when Buspirone is combined with Zopiclone.]
[P01BE02, artemether, The metabolism of Artemether can be decreased when combined with Zopiclone.]
[M02AA03, clofezone, The metabolism of Zopiclone can be decreased when combined with Rabeprazole.]
[N02AF01, butorphanol, The risk or severity of adverse effects can be increased when Butorphanol is combined with Zopiclone.]
[S01GX07, azelastine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Azelastine.]
[L01XK03, rucaparib, The metabolism of Zopiclone can be decreased when combined with Rucaparib.]
[L01EF02, ribociclib, The metabolism of Zopiclone can be decreased when combined with Ribociclib.]
[N07XX16, deutetrabenazine, The risk or severity of sedation and somnolence can be increased when Zopiclone is combined with Deutetrabenazine.]
[N02BF02, pregabalin, The therapeutic efficacy of Zopiclone can be increased when used in combination with Pregabalin.]
[N03AX30, beclamide, The risk or severity of adverse effects can be increased when Beclamide is combined with Zopiclone.]
[S01HA02, benoxinate, The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Zopiclone.]
[J05AE09, tipranavir, The metabolism of Zopiclone can be decreased when combined with Tipranavir.]
[L04AB02, infliximab, The metabolism of Zopiclone can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Zopiclone can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Zopiclone.]
[N04BD03, safinamide, The risk or severity of adverse effects can be increased when Safinamide is combined with Zopiclone.]
[L04AC14, sarilumab, The metabolism of Zopiclone can be decreased when combined with Sarilumab.]
[J01MA23, delafloxacin, The metabolism of Zopiclone can be increased when combined with Delafloxacin.]
[D01AC10, bifonazole, The metabolism of Zopiclone can be decreased when combined with Bifonazole.]
[L01BC06, capecitabine, The metabolism of Zopiclone can be decreased when combined with Capecitabine.]
[L01XX59, enasidenib, The metabolism of Zopiclone can be decreased when combined with Enasidenib.]
[J05AG03, efavirenz, The metabolism of Zopiclone can be decreased when combined with Efavirenz.]
[N04AA11, bornaprine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Bornaprine.]
[N05AD06, bromperidol, The risk or severity of adverse effects can be increased when Bromperidol is combined with Zopiclone.]
[N05CD09, brotizolam, The risk or severity of adverse effects can be increased when Brotizolam is combined with Zopiclone.]
[L01EL02, acalabrutinib, The metabolism of Zopiclone can be decreased when combined with Acalabrutinib.]
[N05CA03, butobarbital, The risk or severity of adverse effects can be increased when Butobarbital is combined with Zopiclone.]
[J05AX18, letermovir, The metabolism of Zopiclone can be decreased when combined with Letermovir.]
[N06AA15, butriptyline, The risk or severity of adverse effects can be increased when Butriptyline is combined with Zopiclone.]
[N01BX04, capsaicin, The metabolism of Zopiclone can be decreased when combined with Capsaicin.]
[N05CA08, butylvinal, The risk or severity of adverse effects can be increased when Vinylbital is combined with Zopiclone.]
[L02BB05, apalutamide, The metabolism of Zopiclone can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Zopiclone can be increased when combined with Carbamazepine.]
[A03AA03, camylofine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Camylofin.]
[R06AA08, carbinoxamine, The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Zopiclone.]
[C07AG02, carvedilol, The metabolism of Zopiclone can be decreased when combined with Carvedilol.]
[B02BX09, fostamatinib, The metabolism of Zopiclone can be decreased when combined with Fostamatinib.]
[N03AX24, cannabidiol, The risk or severity of adverse effects can be increased when Cannabidiol is combined with Zopiclone.]
[B02BX08, avatrombopag, The metabolism of Zopiclone can be increased when combined with Avatrombopag.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Zopiclone.]
[L01XX62, ivosidenib, The metabolism of Zopiclone can be increased when combined with Ivosidenib.]
[N03AX17, stiripentol, The metabolism of Zopiclone can be decreased when combined with Stiripentol.]
[J05AX24, tecovirimat, The metabolism of Zopiclone can be increased when combined with Tecovirimat.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Zopiclone.]
[S01GX12, cetirizine, The risk or severity of adverse effects can be increased when Cetirizine is combined with Zopiclone.]
[N05CM04, carbromal, The risk or severity of adverse effects can be increased when Carbromal is combined with Zopiclone.]
[A10BB06, carbutamide, The metabolism of Carbutamide can be decreased when combined with Zopiclone.]
[N01BA04, chloroprocaine, The risk or severity of adverse effects can be increased when Chloroprocaine is combined with Zopiclone.]
[R06AA06, chlorphenoxamine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Chlorphenoxamine.]
[M01AC05, lornoxicam, The metabolism of Lornoxicam can be decreased when combined with Zopiclone.]
[M03BA02, carisoprodol, The risk or severity of adverse effects can be increased when Carisoprodol is combined with Zopiclone.]
[R03BB08, revefenacin, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Revefenacin.]
[L04AA39, emapalumab, The metabolism of Zopiclone can be increased when combined with Emapalumab.]
[L01XJ03, glasdegib, The metabolism of Glasdegib can be decreased when combined with Zopiclone.]
[A03FA08, cinitapride, The risk or severity of adverse effects can be increased when Cinitapride is combined with Zopiclone.]
[P02BX04, triclabendazole, The metabolism of Zopiclone can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The risk or severity of adverse effects can be increased when Zopiclone is combined with Esketamine.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Zopiclone.]
[J01FA09, clarithromycin, The metabolism of Zopiclone can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, The risk or severity of adverse effects can be increased when Solriamfetol is combined with Zopiclone.]
[N06AX29, brexanolone, The risk or severity of adverse effects can be increased when Brexanolone is combined with Zopiclone.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Zopiclone.]
[N05BA09, clobazam, The risk or severity of adverse effects can be increased when Clobazam is combined with Zopiclone.]
[N05BA22, cloxazolam, The risk or severity of adverse effects can be increased when Cloxazolam is combined with Zopiclone.]
[C09CA06, candesartan, The metabolism of Zopiclone can be decreased when combined with Candesartan.]
[L04AB01, etanercept, The metabolism of Zopiclone can be increased when combined with Etanercept.]
[L01EM03, alpelisib, The serum concentration of Zopiclone can be decreased when it is combined with Alpelisib.]
[N05AA06, cyamemazine, The risk or severity of adverse effects can be increased when Cyamemazine is combined with Zopiclone.]
[M03BX08, cyclobenzaprine, The risk or severity of CNS depression can be increased when Cyclobenzaprine is combined with Zopiclone.]
[N07XX11, pitolisant, The serum concentration of Zopiclone can be decreased when it is combined with Pitolisant.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Zopiclone.]
[G04BE04, yohimbine, The risk or severity of adverse effects can be increased when Yohimbine is combined with Zopiclone.]
[N02CC08, lasmiditan, The risk or severity of adverse effects can be increased when Lasmiditan is combined with Zopiclone.]
[G03AC09, desogestrel, The metabolism of Zopiclone can be decreased when combined with Desogestrel.]
[B06AX03, voxelotor, The metabolism of Voxelotor can be decreased when combined with Zopiclone.]
[N03AX25, cenobamate, The serum concentration of Zopiclone can be decreased when it is combined with Cenobamate.]
[R06AB06, dexbrompheniramine, The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Zopiclone.]
[N02AX03, dezocine, The risk or severity of adverse effects can be increased when Dezocine is combined with Zopiclone.]
[L01EX18, avapritinib, The metabolism of Zopiclone can be decreased when combined with Avapritinib.]
[N05CM21, lemborexant, The risk or severity of adverse effects can be increased when Lemborexant is combined with Zopiclone.]
[N05AD10, lumateperone, The risk or severity of adverse effects can be increased when Lumateperone is combined with Zopiclone.]
[M01AX21, diacetylrhein, The metabolism of Zopiclone can be decreased when combined with Diacerein.]
[J05AB16, remdesivir, The metabolism of Zopiclone can be decreased when combined with Remdesivir.]
[H02CA02, osilodrostat, The metabolism of Zopiclone can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Zopiclone can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, The risk or severity of adverse effects can be increased when Frovatriptan is combined with Zopiclone.]
[L04AA38, ozanimod, The metabolism of Ozanimod can be decreased when combined with Zopiclone.]
[N05CC04, dichloralphenazone, The risk or severity of adverse effects can be increased when Dichloralphenazone is combined with Zopiclone.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Zopiclone.]
[A07DA04, difenoxin, The risk or severity of adverse effects can be increased when Difenoxin is combined with Zopiclone.]
[N02AA08, dihydrocodeine, The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Zopiclone.]
[N02CC06, eletriptan, The risk or severity of adverse effects can be increased when Eletriptan is combined with Zopiclone.]
[M01AH02, rofecoxib, The metabolism of Zopiclone can be decreased when combined with Rofecoxib.]
[L01XF03, bexarotene, The metabolism of Zopiclone can be decreased when combined with Bexarotene.]
[C08CA16, clevidipine, The metabolism of Zopiclone can be decreased when combined with Clevidipine.]
[C01BD07, dronedarone, The metabolism of Zopiclone can be decreased when combined with Dronedarone.]
[N03AG02, dipropylacetamide, The risk or severity of adverse effects can be increased when Valpromide is combined with Zopiclone.]
[J01FA13, dirithromycin, The metabolism of Zopiclone can be decreased when combined with Dirithromycin.]
[S03AA08, chloramphenicol, The metabolism of Zopiclone can be decreased when combined with Chloramphenicol.]
[N05BA02, chlordiazepoxide, The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Zopiclone.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Zopiclone.]
[A03AA08, dihexyverine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Dihexyverine.]
[G04BD09, trospium, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Trospium.]
[L01EX22, selpercatinib, The serum concentration of Zopiclone can be increased when it is combined with Selpercatinib.]
[N05CM02, chlormethiazole, The risk or severity of adverse effects can be increased when Clomethiazole is combined with Zopiclone.]
[M03BB02, chlormezanone, The risk or severity of adverse effects can be increased when Chlormezanone is combined with Zopiclone.]
[R02AD04, dyclonine, The risk or severity of adverse effects can be increased when Dyclonine is combined with Zopiclone.]
[P01BB01, proguanil, The metabolism of Zopiclone can be decreased when combined with Proguanil.]
[N05CD14, remimazolam, The risk or severity of adverse effects can be increased when Remimazolam is combined with Zopiclone.]
[L04AC19, satralizumab, The serum concentration of Zopiclone can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Zopiclone is combined with Oliceridine.]
[P01BA01, chloroquine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Zopiclone.]
[L01EX23, pralsetinib, The metabolism of Zopiclone can be decreased when combined with Pralsetinib.]
[R06AB04, chlorpheniramine, The risk or severity of adverse effects can be increased when Chlorpheniramine is combined with Zopiclone.]
[N05AA01, chlorpromazine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Chlorpromazine.]
[A10BB02, chlorpropamide, The metabolism of Zopiclone can be decreased when combined with Chlorpropamide.]
[N05AF03, chlorprothixene, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Chlorprothixene.]
[M03BB03, chlorzoxazone, The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Zopiclone.]
[N05BX03, etifoxine, The risk or severity of adverse effects can be increased when Etifoxine is combined with Zopiclone.]
[N06BX18, vinpocetine, The risk or severity of adverse effects can be increased when Vinpocetine is combined with Zopiclone.]
[N05BA18, ethyl loflazepate, The risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Zopiclone.]
[M01AB08, etodolac, The metabolism of Zopiclone can be decreased when combined with Etodolac.]
[B06AC06, berotralstat, The metabolism of Zopiclone can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Zopiclone can be decreased when combined with Lonafarnib.]
[P03AX07, abametapir, The serum concentration of Zopiclone can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, The metabolism of Zopiclone can be decreased when combined with Tepotinib.]
[M03BA05, febarbamate, The risk or severity of adverse effects can be increased when Febarbamate is combined with Zopiclone.]
[N03AX10, felbamate, The risk or severity of adverse effects can be increased when Felbamate is combined with Zopiclone.]
[R03CC15, formoterol, The metabolism of Zopiclone can be decreased when combined with Formoterol.]
[N01AB05, trichloroethylene, The risk or severity of adverse effects can be increased when Trichloroethylene is combined with Zopiclone.]
[L03AB10, peginterferon alfa-2b, The metabolism of Zopiclone can be increased when combined with Peginterferon alfa-2b.]
[A02BA01, cimetidine, The metabolism of Zopiclone can be decreased when combined with Cimetidine.]
[N02BF01, gabapentin, The risk or severity of adverse effects can be increased when Gabapentin is combined with Zopiclone.]
[N07CA02, cinnarizine, The metabolism of Zopiclone can be decreased when combined with Cinnarizine.]
[L01XX73, sotorasib, The serum concentration of Zopiclone can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The metabolism of Zopiclone can be decreased when combined with Ciprofloxacin.]
[N06AB04, citalopram, The metabolism of Zopiclone can be decreased when combined with Citalopram.]
[C03DA05, finerenone, The metabolism of Finerenone can be decreased when combined with Zopiclone.]
[P01CA03, fexinidazole, The metabolism of Zopiclone can be decreased when combined with Fexinidazole.]
[R06AA04, clemastine, The risk or severity of adverse effects can be increased when Clemastine is combined with Zopiclone.]
[A10BB12, glimepiride, The metabolism of Zopiclone can be decreased when combined with Glimepiride.]
[A10BB08, gliquidone, The metabolism of Gliquidone can be decreased when combined with Zopiclone.]
[N06AX25, St. John's wort extract, The metabolism of Zopiclone can be increased when combined with St. John's Wort.]
[L01EA06, asciminib, The metabolism of Zopiclone can be decreased when combined with Asciminib.]
[L03AB15, ropeginterferon alfa-2b, The risk or severity of neuropsychiatric effects can be increased when Ropeginterferon alfa-2b is combined with Zopiclone.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Zopiclone.]
[J04BA01, clofazimine, The metabolism of Zopiclone can be decreased when combined with Clofazimine.]
[B06AX04, mitapivat, The metabolism of Zopiclone can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Zopiclone.]
[N06AA04, clomipramine, The risk or severity of adverse effects can be increased when Clomipramine is combined with Zopiclone.]
[N03AE01, clonazepam, The risk or severity of adverse effects can be increased when Clonazepam is combined with Zopiclone.]
[S01EA04, clonidine, The risk or severity of sedation can be increased when Clonidine is combined with Zopiclone.]
[C01EB24, mavacamten, The serum concentration of Zopiclone can be decreased when it is combined with Mavacamten.]
[N05AH06, clothiapine, The risk or severity of adverse effects can be increased when Clothiapine is combined with Zopiclone.]
[H01CC04, linzagolix, The serum concentration of Zopiclone can be increased when it is combined with Linzagolix.]
[N05BA21, clotiazepam, The risk or severity of adverse effects can be increased when Clotiazepam is combined with Zopiclone.]
[A04AA01, ondansetron, The risk or severity of adverse effects can be increased when Ondansetron is combined with Zopiclone.]
[A04AA02, granisetron, The risk or severity of adverse effects can be increased when Granisetron is combined with Zopiclone.]
[N05AH02, clozapine, The metabolism of Zopiclone can be decreased when combined with Clozapine.]
[N05BA13, halazepam, The risk or severity of adverse effects can be increased when Halazepam is combined with Zopiclone.]
[H01AC08, somatrogon, The metabolism of Zopiclone can be increased when combined with Somatrogon.]
[S02DA02, cocaine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Cocaine.]
[C02KB01, metyrosine, Zopiclone may increase the sedative activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Zopiclone can be increased when combined with Bimekizumab.]
[R05DA04, codeine, The risk or severity of adverse effects can be increased when Codeine is combined with Zopiclone.]
[M03AC05, hexafluorenium, The risk or severity of adverse effects can be increased when Hexafluronium is combined with Zopiclone.]
[M04AC01, colchicine, The metabolism of Zopiclone can be decreased when combined with Colchicine.]
[A03AB10, hexocyclium, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Hexocyclium.]
[A03BB06, homatropine methylbromide, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Homatropine methylbromide.]
[L04AA13, leflunomide, The metabolism of Zopiclone can be decreased when combined with Leflunomide.]
[N01AB07, desflurane, The risk or severity of adverse effects can be increased when Desflurane is combined with Zopiclone.]
[A04AA03, tropisetron, The risk or severity of adverse effects can be increased when Tropisetron is combined with Zopiclone.]
[C04AX28, ifenprodil, The risk or severity of adverse effects can be increased when Ifenprodil is combined with Zopiclone.]
[A10BX03, nateglinide, The metabolism of Zopiclone can be decreased when combined with Nateglinide.]
[J01FA15, telithromycin, The metabolism of Zopiclone can be decreased when combined with Telithromycin.]
[R06AX27, desloratadine, The risk or severity of adverse effects can be increased when Desloratadine is combined with Zopiclone.]
[M01AH03, valdecoxib, The metabolism of Zopiclone can be decreased when combined with Valdecoxib.]
[A03AX10, isometheptene, The risk or severity of methemoglobinemia can be increased when Zopiclone is combined with Isometheptene.]
[N02CC05, almotriptan, The risk or severity of adverse effects can be increased when Almotriptan is combined with Zopiclone.]
[M01AH04, parecoxib, The metabolism of Parecoxib can be decreased when combined with Zopiclone.]
[J02AC02, itraconazole, The metabolism of Zopiclone can be decreased when combined with Itraconazole.]
[N05BA10, ketazolam, The metabolism of Zopiclone can be decreased when combined with Ketazolam.]
[L01EA01, imatinib, The metabolism of Zopiclone can be decreased when combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Zopiclone can be decreased when combined with Posaconazole.]
[V03AF07, rasburicase, The risk or severity of methemoglobinemia can be increased when Rasburicase is combined with Zopiclone.]
[N03AX09, lamotrigine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Lamotrigine.]
[S01GX02, levocabastine, The risk or severity of adverse effects can be increased when Levocabastine is combined with Zopiclone.]
[N07BC04, lofexidine, The therapeutic efficacy of Zopiclone can be increased when used in combination with Lofexidine.]
[R06AX13, loratadine, The metabolism of Zopiclone can be decreased when combined with Loratadine.]
[N05CD06, lormetazepam, The risk or severity of adverse effects can be increased when Lormetazepam is combined with Zopiclone.]
[C08CA11, manidipine, The metabolism of Zopiclone can be decreased when combined with Manidipine.]
[A03AA04, mebeverine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Mebeverine.]
[N06AX13, medifoxamine, The risk or severity of adverse effects can be increased when Medifoxamine is combined with Zopiclone.]
[R06AD07, mequitazine, The metabolism of Zopiclone can be decreased when combined with Mequitazine.]
[N04AA03, methixene, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Metixene.]
[R06AE03, cyclizine, The risk or severity of adverse effects can be increased when Cyclizine is combined with Zopiclone.]
[N05CA10, cyclobarbital, The risk or severity of adverse effects can be increased when Cyclobarbital is combined with Zopiclone.]
[N05AD03, metylperon, The risk or severity of adverse effects can be increased when Melperone is combined with Zopiclone.]
[J01FA03, midecamycin, The metabolism of Zopiclone can be decreased when combined with Midecamycin.]
[L01AA01, cyclophosphamide, The risk or severity of methemoglobinemia can be increased when Cyclophosphamide is combined with Zopiclone.]
[N06AX07, minaprine, The risk or severity of adverse effects can be increased when Minaprine is combined with Zopiclone.]
[S01XA18, cyclosporine, The metabolism of Zopiclone can be decreased when combined with Cyclosporine.]
[N06AG02, moclobemide, The risk or severity of adverse effects can be increased when Moclobemide is combined with Zopiclone.]
[N06BA07, modafinil, The metabolism of Zopiclone can be decreased when combined with Modafinil.]
[R06AX02, cyproheptadine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Cyproheptadine.]
[C10AA07, rosuvastatin, The metabolism of Zopiclone can be decreased when combined with Rosuvastatin.]
[C03XA02, conivaptan, The metabolism of Zopiclone can be decreased when combined with Conivaptan.]
[M01AH05, etoricoxib, The metabolism of Zopiclone can be decreased when combined with Etoricoxib.]
[G03XA01, danazol, The metabolism of Zopiclone can be decreased when combined with Danazol.]
[M03CA01, dantrolene, The risk or severity of adverse effects can be increased when Dantrolene is combined with Zopiclone.]
[J04BA02, dapsone, The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Zopiclone.]
[L01DB02, daunorubicin, The metabolism of Zopiclone can be decreased when combined with Daunorubicin.]
[N06BX04, deanol, The risk or severity of adverse effects can be increased when Deanol is combined with Zopiclone.]
[A04AD11, nabilone, Nabilone may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.]
[M01AX01, nabumetone, The metabolism of Zopiclone can be decreased when combined with Nabumetone.]
[N05BA16, nordazepam, The risk or severity of adverse effects can be increased when Nordazepam is combined with Zopiclone.]
[N06AX06, nefazodone, The metabolism of Zopiclone can be decreased when combined with Nefazodone.]
[N05CM16, niaprazine, The risk or severity of adverse effects can be increased when Niaprazine is combined with Zopiclone.]
[L02BB02, nilutamide, The metabolism of Zopiclone can be decreased when combined with Nilutamide.]
[N03AG06, tiagabine, The risk or severity of adverse effects can be increased when Tiagabine is combined with Zopiclone.]
[M03AC11, cisatracurium, The risk or severity of adverse effects can be increased when Cisatracurium is combined with Zopiclone.]
[R05DA06, normethadone, The risk or severity of adverse effects can be increased when Normethadone is combined with Zopiclone.]
[N06AB10, escitalopram, The risk or severity of adverse effects can be increased when Zopiclone is combined with Escitalopram.]
[G04BD08, solifenacin, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Solifenacin.]
[N06AA01, desipramine, The metabolism of Zopiclone can be decreased when combined with Desipramine.]
[N03AF02, oxcarbazepine, The metabolism of Zopiclone can be decreased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Zopiclone can be decreased when combined with Dexamethasone.]
[N06BX07, oxiracetam, The risk or severity of adverse effects can be increased when Oxiracetam is combined with Zopiclone.]
[N04AA08, dexetimide, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Dexetimide.]
[G04BD04, oxybutynin, The metabolism of Zopiclone can be decreased when combined with Oxybutynin.]
[A03AA01, oxyphencyclimine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Oxyphencyclimine.]
[L04AB04, adalimumab, The metabolism of Zopiclone can be increased when combined with Adalimumab.]
[R05DA09, dextromethorphan, The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Zopiclone.]
[N03AC01, paramethadione, The risk or severity of adverse effects can be increased when Paramethadione is combined with Zopiclone.]
[N02AC01, dextromoramide, The risk or severity of adverse effects can be increased when Dextromoramide is combined with Zopiclone.]
[N06AB05, paroxetine, The metabolism of Zopiclone can be decreased when combined with Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Zopiclone can be decreased when combined with Clopidogrel.]
[N07BC06, heroin, The risk or severity of adverse effects can be increased when Diamorphine is combined with Zopiclone.]
[A03AX15, peppermint oil, The metabolism of Zopiclone can be decreased when combined with Peppermint oil.]
[N05BA01, diazepam, The metabolism of Zopiclone can be decreased when combined with Diazepam.]
[N03AX07, phenacemide, The risk or severity of adverse effects can be increased when Phenacemide is combined with Zopiclone.]
[N03AD02, phensuximide, The risk or severity of adverse effects can be increased when Phensuximide is combined with Zopiclone.]
[N06AA08, dibenzepin, The risk or severity of adverse effects can be increased when Dibenzepin is combined with Zopiclone.]
[S02DA04, dibucaine, The risk or severity of adverse effects can be increased when Cinchocaine is combined with Zopiclone.]
[S01BC03, diclofenac, The metabolism of Zopiclone can be decreased when combined with Diclofenac.]
[A03AA07, dicyclomine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.]
[A10BG03, pioglitazone, The metabolism of Zopiclone can be decreased when combined with Pioglitazone.]
[N05AD05, pipamperone, The risk or severity of adverse effects can be increased when Pipamperone is combined with Zopiclone.]
[A03AB14, pipenzolate, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Pipenzolate.]
[L01EB02, erlotinib, The metabolism of Zopiclone can be decreased when combined with Erlotinib.]
[A08AA03, diethylpropion, The risk or severity of adverse effects can be increased when Diethylpropion is combined with Zopiclone.]
[L02AA01, diethylstilbestrol, The metabolism of Zopiclone can be decreased when combined with Diethylstilbestrol.]
[C08CA03, isradipine, The metabolism of Zopiclone can be decreased when combined with Isradipine.]
[A03AB11, poldine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Poldine.]
[N02CA01, dihydroergotamine, The metabolism of Zopiclone can be decreased when combined with Dihydroergotamine.]
[N02AA03, hydromorphone, The risk or severity of adverse effects can be increased when Hydromorphone is combined with Zopiclone.]
[J05AE08, atazanavir, The metabolism of Zopiclone can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The metabolism of Zopiclone can be decreased when combined with Treprostinil.]
[D04AB07, pramoxine, The risk or severity of adverse effects can be increased when Pramocaine is combined with Zopiclone.]
[C08DB01, diltiazem, The metabolism of Zopiclone can be decreased when combined with Diltiazem.]
[R06AA11, dimenhydrinate, The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Zopiclone.]
[M03BX03, pridinol, The risk or severity of adverse effects can be increased when Pridinol is combined with Zopiclone.]
[R06AB03, dimethindene, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Dimetindene.]
[M02AX03, dimethyl sulfoxide, The metabolism of Zopiclone can be decreased when combined with Dimethyl sulfoxide.]
[N03AG05, progabide, The risk or severity of adverse effects can be increased when Progabide is combined with Zopiclone.]
[C05CA03, diosmin, The metabolism of Zopiclone can be decreased when combined with Diosmin.]
[R06AA02, diphenhydramine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Diphenhydramine.]
[A07DA01, diphenoxylate, The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Zopiclone.]
[N05CD10, quazepam, The risk or severity of adverse effects can be increased when Quazepam is combined with Zopiclone.]
[N06BA11, dexmethylphenidate, The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Zopiclone.]
[N06AA23, quinupramine, The risk or severity of adverse effects can be increased when Quinupramine is combined with Zopiclone.]
[A03FA02, cisapride, The risk or severity of adverse effects can be increased when Cisapride is combined with Zopiclone.]
[N05AL04, remoxipride, The risk or severity of adverse effects can be increased when Remoxipride is combined with Zopiclone.]
[C01BA03, disopyramide, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Disopyramide.]
[S02AA12, rifamycin SV, The metabolism of Zopiclone can be decreased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Zopiclone can be increased when combined with Rifapentine.]
[N07XX02, riluzole, The risk or severity of adverse effects can be increased when Riluzole is combined with Zopiclone.]
[N05AX08, risperidone, The risk or severity of adverse effects can be increased when Risperidone is combined with Zopiclone.]
[R06AE09, levocetirizine, The risk or severity of adverse effects can be increased when Levocetirizine is combined with Zopiclone.]
[N01BB09, ropivacaine, The risk or severity of adverse effects can be increased when Ropivacaine is combined with Zopiclone.]
[L01EX01, sunitinib, The metabolism of Zopiclone can be decreased when combined with Sunitinib.]
[A04AD12, aprepitant, The metabolism of Zopiclone can be decreased when combined with Aprepitant.]
[L01XG01, bortezomib, The metabolism of Zopiclone can be decreased when combined with Bortezomib.]
[S01BC05, ketorolac, The metabolism of Zopiclone can be decreased when combined with Ketorolac.]
[C01EB18, ranolazine, The metabolism of Zopiclone can be decreased when combined with Ranolazine.]
[R03AC12, salmeterol, The metabolism of Zopiclone can be decreased when combined with Salmeterol.]
[A03FA03, domperidone, The metabolism of Zopiclone can be decreased when combined with Domperidone.]
[N06AA16, dothiepin, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Dosulepin.]
[N06AA12, doxepin, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Doxepin.]
[L01DB01, doxorubicin, The metabolism of Zopiclone can be decreased when combined with Doxorubicin.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.]
[N06AB06, sertraline, The risk or severity of adverse effects can be increased when Zopiclone is combined with Sertraline.]
[N01AB08, sevoflurane, The risk or severity of adverse effects can be increased when Sevoflurane is combined with Zopiclone.]
[N05AD08, droperidol, Droperidol may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.]
[A08AA10, sibutramine, The risk or severity of adverse effects can be increased when Zopiclone is combined with Sibutramine.]
[C10AA01, simvastatin, The metabolism of Zopiclone can be decreased when combined with Simvastatin.]
[N05AL02, sultopride, The risk or severity of adverse effects can be increased when Sultopride is combined with Zopiclone.]
[N02CC01, sumatriptan, The risk or severity of adverse effects can be increased when Sumatriptan is combined with Zopiclone.]
[M01AC02, tenoxicam, The metabolism of Zopiclone can be decreased when combined with Tenoxicam.]
[D01BA02, terbinafine, The metabolism of Zopiclone can be decreased when combined with Terbinafine.]
[M03BX07, tetrazepam, The risk or severity of adverse effects can be increased when Tetrazepam is combined with Zopiclone.]
[M03BX05, thiocolchicoside, The risk or severity of adverse effects can be increased when Thiocolchicoside is combined with Zopiclone.]
[N05AB05, thiopropazate, The risk or severity of adverse effects can be increased when Thiopropazate is combined with Zopiclone.]
[G04BD01, emepronium, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Emepronium.]
[N06AX14, tianeptine, The risk or severity of adverse effects can be increased when Tianeptine is combined with Zopiclone.]
[G01AF08, tioconazole, The metabolism of Zopiclone can be decreased when combined with Tioconazole.]
[N05BA23, tofisopam, The metabolism of Zopiclone can be decreased when combined with Tofisopam.]
[N06AG03, toloxatone, The risk or severity of adverse effects can be increased when Toloxatone is combined with Zopiclone.]
[N03AX11, topiramate, The risk or severity of adverse effects can be increased when Topiramate is combined with Zopiclone.]
[C03CA04, torsemide, The metabolism of Zopiclone can be decreased when combined with Torasemide.]
[N05CD11, triazulenone, The risk or severity of adverse effects can be increased when Loprazolam is combined with Zopiclone.]
[N05CC01, chloral hydrate, The risk or severity of adverse effects can be increased when Chloral hydrate is combined with Zopiclone.]
[N05CM07, triclofos, The risk or severity of adverse effects can be increased when Triclofos is combined with Zopiclone.]
[A03AB08, tridihexethyl, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Tridihexethyl.]
[R06AA10, trimethobenzamide, The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Zopiclone.]
[N04AA12, tropatepine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Tropatepine.]
[N01AB04, enflurane, The risk or severity of adverse effects can be increased when Enflurane is combined with Zopiclone.]
[C02CA06, urapidil, The risk or severity of adverse effects can be increased when Urapidil is combined with Zopiclone.]
[N05AL06, veralipride, The risk or severity of adverse effects can be increased when Veralipride is combined with Zopiclone.]
[S01GX10, epinastine, The risk or severity of adverse effects can be increased when Epinastine is combined with Zopiclone.]
[N06AX16, venlafaxine, The risk or severity of adverse effects can be increased when Venlafaxine is combined with Zopiclone.]
[C08CA12, mepirodipine, The metabolism of Zopiclone can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The metabolism of Zopiclone can be decreased when combined with Epinephrine.]
[N05CF02, zolpidem, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.]
[N03AX15, zonisamide, The risk or severity of adverse effects can be increased when Zonisamide is combined with Zopiclone.]
[S01AA13, fusidic acid, The metabolism of Zopiclone can be decreased when combined with Fusidic acid.]
[N07XX04, sodium oxybate, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.]
[M01AG01, mefenamic acid, The metabolism of Zopiclone can be decreased when combined with Mefenamic acid.]
[N05AX11, zotepine, The risk or severity of adverse effects can be increased when Zotepine is combined with Zopiclone.]
[C02AC02, guanfacine, The risk or severity of adverse effects can be increased when Guanfacine is combined with Zopiclone.]
[C01BG01, moricizine, The risk or severity of adverse effects can be increased when Moricizine is combined with Zopiclone.]
[G02AB03, ergonovine, The risk or severity of adverse effects can be increased when Ergometrine is combined with Zopiclone.]
[C04AE01, ergoloid mesylates, USP, The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Zopiclone.]
[N02CA02, ergotamine, The metabolism of Zopiclone can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The metabolism of Zopiclone can be decreased when combined with Erythromycin.]
[N05CD04, estazolam, The risk or severity of adverse effects can be increased when Estazolam is combined with Zopiclone.]
[G03CA03, estradiol, The metabolism of Zopiclone can be decreased when combined with Estradiol.]
[J04AK02, ethambutol, The metabolism of Zopiclone can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The metabolism of Zopiclone can be decreased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Zopiclone can be decreased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Zopiclone can be decreased when combined with Fluvastatin.]
[N05CM08, ethchlorvynol, The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Zopiclone.]
[L02AA03, ethinyl estradiol, The metabolism of Zopiclone can be decreased when combined with Ethinylestradiol.]
[N04AA05, profenamine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Profenamine.]
[N03AD01, ethosuximide, The risk or severity of adverse effects can be increased when Ethosuximide is combined with Zopiclone.]
[N03AB01, ethotoin, The risk or severity of adverse effects can be increased when Ethotoin is combined with Zopiclone.]
[M01AC06, meloxicam, The metabolism of Zopiclone can be decreased when combined with Meloxicam.]
[S01XA06, ethylmorphine, The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Zopiclone.]
[N01AX07, etomidate, The risk or severity of adverse effects can be increased when Etomidate is combined with Zopiclone.]
[L01CB01, etoposide, The metabolism of Zopiclone can be decreased when combined with Etoposide.]
[N05AE03, sertindole, The risk or severity of adverse effects can be increased when Sertindole is combined with Zopiclone.]
[L04AD02, tacrolimus, The metabolism of Zopiclone can be decreased when combined with Tacrolimus.]
[R06AX11, astemizole, The metabolism of Zopiclone can be decreased when combined with Astemizole.]
[R06AX12, terfenadine, The metabolism of Zopiclone can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The risk or severity of adverse effects can be increased when Bupropion is combined with Zopiclone.]
[N06AB08, fluvoxamine, The metabolism of Zopiclone can be decreased when combined with Fluvoxamine.]
[C08CA02, felodipine, The metabolism of Zopiclone can be decreased when combined with Felodipine.]
[N03AX26, fenfluramine, The risk or severity of adverse effects can be increased when Fenfluramine is combined with Zopiclone.]
[N02AB03, fentanyl, The risk or severity of adverse effects can be increased when Fentanyl is combined with Zopiclone.]
[G04BD02, flavoxate, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Flavoxate.]
[C01BC04, flecainide, The metabolism of Zopiclone can be decreased when combined with Flecainide.]
[J02AC01, fluconazole, The metabolism of Zopiclone can be decreased when combined with Fluconazole.]
[V03AB25, flumazenil, Flumazenil may decrease the sedative activities of Zopiclone.]
[N07CA03, flunarizine, The risk or severity of adverse effects can be increased when Flunarizine is combined with Zopiclone.]
[N05CD03, flunitrazepam, The risk or severity of adverse effects can be increased when Flunitrazepam is combined with Zopiclone.]
[N06AA14, melitracen, The risk or severity of adverse effects can be increased when Melitracen is combined with Zopiclone.]
[V03AZ01, ethanol, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Ethanol.]
[L01BC09, floxuridine, The metabolism of Zopiclone can be decreased when combined with Floxuridine.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be decreased when combined with Zopiclone.]
[N06AB03, fluoxetine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.]
[N05AF01, flupenthixol, Flupentixol may increase the sedative activities of Zopiclone.]
[N05AB02, fluphenazine, The risk or severity of adverse effects can be increased when Fluphenazine is combined with Zopiclone.]
[N05CD01, flurazepam, The risk or severity of adverse effects can be increased when Flurazepam is combined with Zopiclone.]
[S01BC04, flurbiprofen, The metabolism of Zopiclone can be decreased when combined with Flurbiprofen.]
[N05AG01, fluspirilene, The risk or severity of adverse effects can be increased when Fluspirilene is combined with Zopiclone.]
[L02BB01, flutamide, The risk or severity of methemoglobinemia can be increased when Flutamide is combined with Zopiclone.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Zopiclone.]
[M03AA01, alcuronium, The risk or severity of adverse effects can be increased when Alcuronium is combined with Zopiclone.]
[G01AX06, furazolidone, The risk or severity of adverse effects can be increased when Furazolidone is combined with Zopiclone.]
[J05AE10, darunavir, The metabolism of Zopiclone can be decreased when combined with Darunavir.]
[N05CF04, eszopiclone, The risk or severity of CNS depression can be increased when Zopiclone is combined with Eszopiclone.]
[N05AL05, amisulpride, The risk or severity of adverse effects can be increased when Amisulpride is combined with Zopiclone.]
[M03AC02, gallamine, The risk or severity of adverse effects can be increased when Gallamine is combined with Zopiclone.]
[N03AA04, barbexaclone, The risk or severity of adverse effects can be increased when Barbexaclone is combined with Zopiclone.]
[N06AX08, bifemelane, The risk or severity of adverse effects can be increased when Bifemelane is combined with Zopiclone.]
[C10AB04, gemfibrozil, The metabolism of Zopiclone can be decreased when combined with Gemfibrozil.]
[L01EA02, dasatinib, The metabolism of Zopiclone can be decreased when combined with Dasatinib.]
[N04BC06, cabergoline, The metabolism of Zopiclone can be decreased when combined with Cabergoline.]
[J05AG04, etravirine, The metabolism of Zopiclone can be decreased when combined with Etravirine.]
[N03AD03, methsuximide, The risk or severity of adverse effects can be increased when Methsuximide is combined with Zopiclone.]
[N01AH02, alfentanil, The risk or severity of adverse effects can be increased when Alfentanil is combined with Zopiclone.]
[L01EH01, lapatinib, The metabolism of Zopiclone can be decreased when combined with Lapatinib.]
[A10BB01, glyburide, The metabolism of Zopiclone can be decreased when combined with Glyburide.]
[A10BB09, gliclazide, The metabolism of Zopiclone can be decreased when combined with Gliclazide.]
[A10BB07, glipizide, The metabolism of Zopiclone can be decreased when combined with Glipizide.]
[N05CM18, dexmedetomidine, The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Zopiclone.]
[N05CE01, glutethimide, The risk or severity of adverse effects can be increased when Glutethimide is combined with Zopiclone.]
[C05AE01, nitroglycerin, The risk or severity of methemoglobinemia can be increased when Nitroglycerin is combined with Zopiclone.]
[C02CA04, doxazosin, The metabolism of Zopiclone can be decreased when combined with Doxazosin.]
[L01EX02, sorafenib, The metabolism of Zopiclone can be decreased when combined with Sorafenib.]
[B01AA12, fluindione, The metabolism of Fluindione can be decreased when combined with Zopiclone.]
[P01BX01, halofantrine, The metabolism of Halofantrine can be decreased when combined with Zopiclone.]
[N05AD01, haloperidol, The risk or severity of CNS depression can be increased when Haloperidol is combined with Zopiclone.]
[N01AB01, halothane, The risk or severity of adverse effects can be increased when Halothane is combined with Zopiclone.]
[N05AH04, quetiapine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.]
[N02CX03, iprazochrome, The risk or severity of adverse effects can be increased when Iprazochrome is combined with Zopiclone.]
[N05CA21, allobarbital, The risk or severity of adverse effects can be increased when Allobarbital is combined with Zopiclone.]
[C09CA01, losartan, The metabolism of Zopiclone can be decreased when combined with Losartan.]
[N05CA16, hexobarbital, The risk or severity of adverse effects can be increased when Hexobarbital is combined with Zopiclone.]
[J05AG01, nevirapine, The metabolism of Zopiclone can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, The metabolism of Zopiclone can be decreased when combined with Nilvadipine.]
[C02DB02, hydralazine, The metabolism of Zopiclone can be decreased when combined with Hydralazine.]
[R05DA03, hydrocodone, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.]
[S02BA01, hydrocortisone, The metabolism of Zopiclone can be increased when combined with Hydrocortisone.]
[G04BD06, propiverine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Propiverine.]
[P01BA02, hydroxychloroquine, The metabolism of Hydroxychloroquine can be decreased when combined with Zopiclone.]
[N05AX07, prothipendyl, The risk or severity of adverse effects can be increased when Prothipendyl is combined with Zopiclone.]
[L01XX05, hydroxyurea, The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Zopiclone.]
[N05BB01, hydroxyzine, Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.]
[J04AB04, rifabutin, The metabolism of Zopiclone can be increased when combined with Rifabutin.]
[R02AX02, ibuprofen, The metabolism of Zopiclone can be decreased when combined with Ibuprofen.]
[L01DB06, idarubicin, The metabolism of Zopiclone can be decreased when combined with Idarubicin.]
[L01AA06, ifosfamide, The metabolism of Zopiclone can be decreased when combined with Ifosfamide.]
[N01AH03, sufentanil, The risk or severity of adverse effects can be increased when Sufentanil is combined with Zopiclone.]
[N06AA02, imipramine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Imipramine.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Zopiclone.]
[M03BX02, tizanidine, The risk or severity of adverse effects can be increased when Tizanidine is combined with Zopiclone.]
[L01CE01, topotecan, The metabolism of Zopiclone can be decreased when combined with Topotecan.]
[S01BC01, indomethacin, The metabolism of Zopiclone can be decreased when combined with Indomethacin.]
[N06AX17, milnacipran, The metabolism of Zopiclone can be decreased when combined with Milnacipran.]
[A03AA30, piperidolate, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Piperidolate.]
[N01BB08, articaine, The risk or severity of adverse effects can be increased when Articaine is combined with Zopiclone.]
[A10BH01, sitagliptin, The metabolism of Sitagliptin can be decreased when combined with Zopiclone.]
[N05BA12, alprazolam, The risk or severity of adverse effects can be increased when Alprazolam is combined with Zopiclone.]
[N05CH02, ramelteon, The risk or severity of adverse effects can be increased when Ramelteon is combined with Zopiclone.]
[R06AE01, buclizine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Buclizine.]
[C10AA06, cerivastatin, The metabolism of Zopiclone can be decreased when combined with Cerivastatin.]
[C07AA01, alprenolol, The risk or severity of adverse effects can be increased when Alprenolol is combined with Zopiclone.]
[N06AA13, iprindole, The risk or severity of adverse effects can be increased when Iprindole is combined with Zopiclone.]
[N06AF05, iproniazid, The risk or severity of adverse effects can be increased when Iproniazid is combined with Zopiclone.]
[N05AA07, chlorproethazine, The risk or severity of adverse effects can be increased when Chlorproethazine is combined with Zopiclone.]
[N06AF01, isocarboxazid, The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Zopiclone.]
[P01AX06, atovaquone, The metabolism of Zopiclone can be decreased when combined with Atovaquone.]
[N01AB06, isoflurane, The risk or severity of adverse effects can be increased when Isoflurane is combined with Zopiclone.]
[N04BX02, entacapone, The risk or severity of adverse effects can be increased when Entacapone is combined with Zopiclone.]
[J04AC01, isoniazid, The metabolism of Zopiclone can be decreased when combined with Isoniazid.]
[C05AE02, isosorbide dinitrate, The risk or severity of methemoglobinemia can be increased when Isosorbide dinitrate is combined with Zopiclone.]
[N06AX18, reboxetine, The risk or severity of adverse effects can be increased when Reboxetine is combined with Zopiclone.]
[L04AC07, tocilizumab, The metabolism of Zopiclone can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The risk or severity of adverse effects can be increased when Ketamine is combined with Zopiclone.]
[C02KD01, ketanserin, The risk or severity of adverse effects can be increased when Ketanserin is combined with Zopiclone.]
[B01AC22, prasugrel, The metabolism of Prasugrel can be decreased when combined with Zopiclone.]
[J02AB02, ketoconazole, The metabolism of Zopiclone can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Olanzapine.]
[M02AA10, ketoprofen, The metabolism of Zopiclone can be decreased when combined with Ketoprofen.]
[V03AC03, deferasirox, The metabolism of Zopiclone can be decreased when combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Zopiclone can be increased when combined with Abatacept.]
[N04BC09, rotigotine, Zopiclone may increase the sedative activities of Rotigotine.]
[N03AX18, lacosamide, The risk or severity of adverse effects can be increased when Lacosamide is combined with Zopiclone.]
[N04BA01, levodopa, The risk or severity of adverse effects can be increased when Levodopa is combined with Zopiclone.]
[S02DA01, lidocaine, The risk or severity of adverse effects can be increased when Lidocaine is combined with Zopiclone.]
[N06BA13, armodafinil, The metabolism of Zopiclone can be decreased when combined with Armodafinil.]
[N02CA07, lisuride, The risk or severity of adverse effects can be increased when Lisuride is combined with Zopiclone.]
[N06AA07, lofepramine, The risk or severity of adverse effects can be increased when Lofepramine is combined with Zopiclone.]
[A07DA03, loperamide, The metabolism of Zopiclone can be decreased when combined with Loperamide.]
[N05BA06, lorazepam, The risk or severity of adverse effects can be increased when Lorazepam is combined with Zopiclone.]
[C10AA02, lovastatin, The metabolism of Zopiclone can be decreased when combined with Lovastatin.]
[N05AH01, loxapine, The risk or severity of adverse effects can be increased when Loxapine is combined with Zopiclone.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Zopiclone.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Zopiclone can be increased when used in combination with Magnesium sulfate.]
[L01EA03, nilotinib, The metabolism of Zopiclone can be decreased when combined with Nilotinib.]
[N06AA21, maprotiline, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Maprotiline.]
[A08AA05, mazindol, The risk or severity of adverse effects can be increased when Mazindol is combined with Zopiclone.]
[R06AE05, meclizine, The risk or severity of adverse effects can be increased when Meclizine is combined with Zopiclone.]
[N05BA03, medazepam, The risk or severity of adverse effects can be increased when Medazepam is combined with Zopiclone.]
[P01BC02, mefloquine, The metabolism of Zopiclone can be decreased when combined with Mefloquine.]
[N05CH01, melatonin, The risk or severity of adverse effects can be increased when Melatonin is combined with Zopiclone.]
[N02AB02, meperidine, The risk or severity of adverse effects can be increased when Meperidine is combined with Zopiclone.]
[N03AB04, mephenytoin, The risk or severity of adverse effects can be increased when Mephenytoin is combined with Zopiclone.]
[N03AA01, mephobarbital, The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Zopiclone.]
[N01BB03, mepivacaine, The risk or severity of adverse effects can be increased when Mepivacaine is combined with Zopiclone.]
[N05BC01, meprobamate, The risk or severity of adverse effects can be increased when Meprobamate is combined with Zopiclone.]
[N02AX05, meptazinol, The risk or severity of adverse effects can be increased when Meptazinol is combined with Zopiclone.]
[N05AC03, mesoridazine, The risk or severity of adverse effects can be increased when Mesoridazine is combined with Zopiclone.]
[N05AX13, paliperidone, The risk or severity of adverse effects can be increased when Paliperidone is combined with Zopiclone.]
[A04AA04, dolasetron, The risk or severity of adverse effects can be increased when Dolasetron is combined with Zopiclone.]
[H01CB03, lanreotide, The metabolism of Zopiclone can be decreased when combined with Lanreotide.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Methadone is combined with Zopiclone.]
[N06BA03, methamphetamine, The risk or severity of adverse effects can be increased when Metamfetamine is combined with Zopiclone.]
[A03AB07, methantheline, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Methantheline.]
[R06AC05, methapyrilene, The risk or severity of adverse effects can be increased when Methapyrilene is combined with Zopiclone.]
[N05CM01, methaqualone, The risk or severity of adverse effects can be increased when Methaqualone is combined with Zopiclone.]
[N03AA30, metharbital, The risk or severity of adverse effects can be increased when Metharbital is combined with Zopiclone.]
[G02CB05, metergoline, The risk or severity of adverse effects can be increased when Metergoline is combined with Zopiclone.]
[H03BB02, methimazole, The metabolism of Zopiclone can be decreased when combined with Methimazole.]
[M03BA03, methocarbamol, The risk or severity of adverse effects can be increased when Methocarbamol is combined with Zopiclone.]
[N05CA15, methohexital, The risk or severity of adverse effects can be increased when Methohexital is combined with Zopiclone.]
[N02BG08, ziconotide, The risk or severity of CNS depression can be increased when Zopiclone is combined with Ziconotide.]
[N05AA02, methotrimeprazine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.]
[N02BG09, methoxyflurane, The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Zopiclone.]
[V04CG05, methylene blue, The metabolism of Zopiclone can be decreased when combined with Methylene blue.]
[G02AB01, methylergonovine, The metabolism of Zopiclone can be decreased when combined with Methylergometrine.]
[N03AF03, rufinamide, The risk or severity of adverse effects can be increased when Rufinamide is combined with Zopiclone.]
[N05CE02, methyprylon, The risk or severity of adverse effects can be increased when Methyprylon is combined with Zopiclone.]
[N02CA04, methysergide, The risk or severity of adverse effects can be increased when Methysergide is combined with Zopiclone.]
[A03FA01, metoclopramide, The risk or severity of sedation can be increased when Metoclopramide is combined with Zopiclone.]
[P01AB01, metronidazole, The metabolism of Zopiclone can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, The metabolism of Zopiclone can be decreased when combined with Metyrapone.]
[N06AX03, mianserin, The risk or severity of adverse effects can be increased when Mianserin is combined with Zopiclone.]
[S02AA13, miconazole, The metabolism of Zopiclone can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Zopiclone.]
[N05CD08, midazolam, The metabolism of Zopiclone can be decreased when combined with Midazolam.]
[G03XB01, mifepristone, The serum concentration of Zopiclone can be increased when it is combined with Mifepristone.]
[C09CA03, valsartan, The metabolism of Zopiclone can be decreased when combined with Valsartan.]
[J01AA08, minocycline, Minocycline may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.]
[L01XX23, mitotane, The metabolism of Zopiclone can be increased when combined with Mitotane.]
[N05AE02, molindone, The risk or severity of adverse effects can be increased when Molindone is combined with Zopiclone.]
[L03AC01, aldesleukin, The metabolism of Zopiclone can be decreased when combined with Aldesleukin.]
[C01BD01, amiodarone, The metabolism of Zopiclone can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Morphine is combined with Zopiclone.]
[A04AA05, palonosetron, The risk or severity of adverse effects can be increased when Palonosetron is combined with Zopiclone.]
[L04AB05, certolizumab pegol, The metabolism of Zopiclone can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Zopiclone can be decreased when combined with Eltrombopag.]
[L01EX03, pazopanib, The metabolism of Zopiclone can be decreased when combined with Pazopanib.]
[M03AC03, vecuronium, The risk or severity of adverse effects can be increased when Vecuronium is combined with Zopiclone.]
[N05CA02, amobarbital, The risk or severity of adverse effects can be increased when Amobarbital is combined with Zopiclone.]
[P01BA06, amodiaquine, The metabolism of Zopiclone can be decreased when combined with Amodiaquine.]
[G03XC01, raloxifene, The metabolism of Zopiclone can be decreased when combined with Raloxifene.]
[N06AA17, amoxapine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Amoxapine.]
[N03AB05, fosphenytoin, The metabolism of Fosphenytoin can be decreased when combined with Zopiclone.]
[N04BC04, ropinirole, Zopiclone may increase the sedative activities of Ropinirole.]
[C04AX21, nafronyl, The risk or severity of adverse effects can be increased when Naftidrofuryl is combined with Zopiclone.]
[N02AF02, nalbuphine, The risk or severity of adverse effects can be increased when Nalbuphine is combined with Zopiclone.]
[V03AB15, naloxone, The metabolism of Zopiclone can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Zopiclone can be increased when combined with Anakinra.]
[S01GA01, naphazoline, The risk or severity of CNS depression can be increased when Naphazoline is combined with Zopiclone.]
[M02AA12, naproxen, The metabolism of Zopiclone can be decreased when combined with Naproxen.]
[A10BG01, troglitazone, The metabolism of Zopiclone can be decreased when combined with Troglitazone.]
[N06AX21, duloxetine, The risk or severity of adverse effects can be increased when Zopiclone is combined with Duloxetine.]
[N04BX01, tolcapone, The risk or severity of adverse effects can be increased when Tolcapone is combined with Zopiclone.]
[L01CD02, docetaxel, The metabolism of Zopiclone can be decreased when combined with Docetaxel.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Remifentanil is combined with Zopiclone.]
[A10BX02, repaglinide, The metabolism of Zopiclone can be decreased when combined with Repaglinide.]
[N05AX14, iloperidone, The risk or severity of adverse effects can be increased when Iloperidone is combined with Zopiclone.]
[N06AX23, desvenlafaxine, The metabolism of Zopiclone can be decreased when combined with Desvenlafaxine.]
[N06AF02, nialamide, The risk or severity of adverse effects can be increased when Nialamide is combined with Zopiclone.]
[C08CA04, nicardipine, The metabolism of Zopiclone can be decreased when combined with Nicardipine.]
[P02DA01, niclosamide, The metabolism of Niclosamide can be decreased when combined with Zopiclone.]
[V03AB22, amyl nitrite, The risk or severity of methemoglobinemia can be increased when Zopiclone is combined with Amyl Nitrite.]
[N05CD02, nitrazepam, The risk or severity of adverse effects can be increased when Nitrazepam is combined with Zopiclone.]
[R07AX01, nitric oxide, The metabolism of Zopiclone can be decreased when combined with Nitric Oxide.]
[J01XE01, nitrofurantoin, The risk or severity of methemoglobinemia can be increased when Nitrofurantoin is combined with Zopiclone.]
[N05CF03, zaleplon, The risk or severity of adverse effects can be increased when Zaleplon is combined with Zopiclone.]
[N04BC05, pramipexole, Zopiclone may increase the sedative activities of Pramipexole.]
[C02DD01, nitroprusside, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Zopiclone.]
[N01AX13, nitrous oxide, The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Zopiclone.]
[N06AX04, nomifensine, The risk or severity of adverse effects can be increased when Nomifensine is combined with Zopiclone.]
[S01AE02, norfloxacin, The metabolism of Zopiclone can be decreased when combined with Norfloxacin.]
[C02KX01, bosentan, The metabolism of Zopiclone can be increased when combined with Bosentan.]
[N06AA10, nortriptyline, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Nortriptyline.]
[R05DA07, noscapine, The metabolism of Zopiclone can be decreased when combined with Noscapine.]
[H01CB02, octreotide, The metabolism of Zopiclone can be decreased when combined with Octreotide.]
[J01FA05, oleandomycin, The metabolism of Zopiclone can be decreased when combined with Oleandomycin.]
[L04AC04, rilonacept, The metabolism of Zopiclone can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Zopiclone can be decreased when combined with Omeprazole.]
[N06AA05, opipramol, The risk or severity of adverse effects can be increased when Opipramol is combined with Zopiclone.]
[N02AA02, opium, The risk or severity of adverse effects can be increased when Opium is combined with Zopiclone.]
[A14AA08, oxandrolone, The metabolism of Zopiclone can be decreased when combined with Oxandrolone.]
[N05BA04, oxazepam, The risk or severity of adverse effects can be increased when Oxazepam is combined with Zopiclone.]
[C07AA02, oxprenolol, The risk or severity of adverse effects can be increased when Oxprenolol is combined with Zopiclone.]
[N02AA05, oxycodone, The risk or severity of adverse effects can be increased when Oxycodone is combined with Zopiclone.]
[A14AA05, oxymetholone, The metabolism of Zopiclone can be decreased when combined with Oxymetholone.]
[N02AA11, oxymorphone, The risk or severity of adverse effects can be increased when Oxymorphone is combined with Zopiclone.]
[N05AE01, oxypertine, The risk or severity of adverse effects can be increased when Oxypertine is combined with Zopiclone.]
[A03AB03, oxyphenonium, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Oxyphenonium.]
[J04AA01, aminosalicylic acid, The risk or severity of methemoglobinemia can be increased when Aminosalicylic acid is combined with Zopiclone.]
[N05AH05, asenapine, The risk or severity of adverse effects can be increased when Asenapine is combined with Zopiclone.]
[N02AX06, tapentadol, Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.]
[M03AC01, pancuronium, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Pancuronium.]
[N05CC05, paraldehyde, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.]
[H02AB05, paramethasone, The metabolism of Zopiclone can be decreased when combined with Paramethasone.]
[C02KC01, pargyline, The risk or severity of adverse effects can be increased when Pargyline is combined with Zopiclone.]
[G04BD11, fesoterodine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Fesoterodine.]
[C07AA23, penbutolol, The risk or severity of adverse effects can be increased when Penbutolol is combined with Zopiclone.]
[N05AG03, penfluridol, The risk or severity of adverse effects can be increased when Penfluridol is combined with Zopiclone.]
[N02AD01, pentazocine, The risk or severity of adverse effects can be increased when Pentazocine is combined with Zopiclone.]
[N05CA01, pentobarbital, The metabolism of Zopiclone can be increased when combined with Pentobarbital.]
[N05AB10, perazine, The risk or severity of adverse effects can be increased when Perazine is combined with Zopiclone.]
[N04BC02, pergolide, The risk or severity of adverse effects can be increased when Pergolide is combined with Zopiclone.]
[N05AB03, perphenazine, The risk or severity of adverse effects can be increased when Perphenazine is combined with Zopiclone.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Zopiclone.]
[N02AD02, phenazocine, The risk or severity of adverse effects can be increased when Phenazocine is combined with Zopiclone.]
[G04BX06, phenazopyridine, The risk or severity of methemoglobinemia can be increased when Zopiclone is combined with Phenazopyridine.]
[N06AF03, phenelzine, The metabolism of Zopiclone can be decreased when combined with Phenelzine.]
[N03AA02, phenobarbital, The metabolism of Zopiclone can be increased when combined with Phenobarbital.]
[N01AH04, phenoperidine, The risk or severity of adverse effects can be increased when Phenoperidine is combined with Zopiclone.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Zopiclone.]
[M02AA01, phenylbutazone, The metabolism of Zopiclone can be decreased when combined with Phenylbutazone.]
[N03AB02, phenytoin, The metabolism of Phenytoin can be decreased when combined with Zopiclone.]
[L04AB06, golimumab, The metabolism of Zopiclone can be increased when combined with Golimumab.]
[L02BB03, bicalutamide, The metabolism of Zopiclone can be decreased when combined with Bicalutamide.]
[C08CX01, mibefradil, The metabolism of Zopiclone can be decreased when combined with Mibefradil.]
[S01EB01, pilocarpine, The metabolism of Zopiclone can be decreased when combined with Pilocarpine.]
[N05AG02, pimozide, The metabolism of Zopiclone can be decreased when combined with Pimozide.]
[C07AA03, pindolol, The risk or severity of adverse effects can be increased when Pindolol is combined with Zopiclone.]
[C10AA05, atorvastatin, The metabolism of Zopiclone can be decreased when combined with Atorvastatin.]
[J05AE01, saquinavir, The metabolism of Zopiclone can be decreased when combined with Saquinavir.]
[N05AC04, pipothiazine, The risk or severity of adverse effects can be increased when Pipotiazine is combined with Zopiclone.]
[A02BX03, pirenzepine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Pirenzepine.]
[N02AC03, pirinitramide, The risk or severity of adverse effects can be increased when Piritramide is combined with Zopiclone.]
[S01BC06, piroxicam, The metabolism of Zopiclone can be decreased when combined with Piroxicam.]
[N02CX01, pizotyline, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Pizotifen.]
[J05AG02, delavirdine, The metabolism of Zopiclone can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Zopiclone can be decreased when combined with Irbesartan.]
[N05CA22, proxibarbal, The risk or severity of adverse effects can be increased when Proxibarbal is combined with Zopiclone.]
[D05AX05, tazarotene, The metabolism of Zopiclone can be decreased when combined with Tazarotene.]
[A10BG02, rosiglitazone, The metabolism of Zopiclone can be decreased when combined with Rosiglitazone.]
[L02BG03, anastrozole, The metabolism of Anastrozole can be decreased when combined with Zopiclone.]
[A03AE01, alosetron, The risk or severity of adverse effects can be increased when Alosetron is combined with Zopiclone.]
[L04AC08, canakinumab, The metabolism of Zopiclone can be increased when combined with Canakinumab.]
[J05AE03, ritonavir, The serum concentration of Zopiclone can be increased when it is combined with Ritonavir.]
[C10AA08, pitavastatin, The metabolism of Pitavastatin can be decreased when combined with Zopiclone.]
[N05BA11, prazepam, The risk or severity of adverse effects can be increased when Prazepam is combined with Zopiclone.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Zopiclone is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Zopiclone can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Zopiclone can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Zopiclone can be increased when combined with Probenecid.]
[S01HA05, procaine, The risk or severity of adverse effects can be increased when Procaine is combined with Zopiclone.]
[L01XB01, procarbazine, The risk or severity of adverse effects can be increased when Procarbazine is combined with Zopiclone.]
[C10AB05, fenofibrate, The metabolism of Zopiclone can be decreased when combined with Fenofibrate.]
[N05AB04, prochlorperazine, The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Zopiclone.]
[N04AA04, procyclidine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Procyclidine.]
[G03DA04, progesterone, The metabolism of Zopiclone can be decreased when combined with Progesterone.]
[N05AA03, promazine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Promazine.]
[R06AD02, promethazine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Promethazine.]
[N01AX04, propanidid, The risk or severity of adverse effects can be increased when Propanidid is combined with Zopiclone.]
[A03AB05, propantheline, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Propantheline.]
[N05AC01, periciazine, The risk or severity of adverse effects can be increased when Periciazine is combined with Zopiclone.]
[N05CM06, propiomazine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Propiomazine.]
[N01AX10, propofol, The metabolism of Zopiclone can be decreased when combined with Propofol.]
[N02AC04, propoxyphene, The metabolism of Zopiclone can be decreased when combined with Dextropropoxyphene.]
[N02CC04, rizatriptan, The risk or severity of adverse effects can be increased when Rizatriptan is combined with Zopiclone.]
[R03DC03, montelukast, The metabolism of Zopiclone can be decreased when combined with Montelukast.]
[N06AA11, protriptyline, The risk or severity of adverse effects can be increased when Protriptyline is combined with Zopiclone.]
[N05AX12, aripiprazole, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Aripiprazole.]
[A03AB15, diphemanil, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Diphemanil.]
[A03AB09, isopropamide, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Isopropamide.]
[S01FA03, methscopolamine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Methscopolamine.]
[N05CA07, talbutal, The risk or severity of adverse effects can be increased when Talbutal is combined with Zopiclone.]
[N05CA09, vinbarbital, The risk or severity of adverse effects can be increased when Vinbarbital is combined with Zopiclone.]
[N05BB02, captodiamine, The risk or severity of adverse effects can be increased when Captodiame is combined with Zopiclone.]
[M03BA04, styramate, The risk or severity of adverse effects can be increased when Styramate is combined with Zopiclone.]
[P02CC01, pyrantel, The risk or severity of adverse effects can be increased when Pyrantel is combined with Zopiclone.]
[R06AC01, pyrilamine, The risk or severity of adverse effects can be increased when Mepyramine is combined with Zopiclone.]
[P01BD01, pyrimethamine, The metabolism of Zopiclone can be decreased when combined with Pyrimethamine.]
[C01BA01, quinidine, The metabolism of Zopiclone can be decreased when combined with Quinidine.]
[P01BC01, quinine, The metabolism of Zopiclone can be decreased when combined with Quinine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Reserpine is combined with Zopiclone.]
[J04AB02, rifampin, The metabolism of Zopiclone can be increased when combined with Rifampicin.]
[N06AX01, 5-hydroxytryptophan, The risk or severity of adverse effects can be increased when Oxitriptan is combined with Zopiclone.]
[J01FA06, roxithromycin, The metabolism of Zopiclone can be decreased when combined with Roxithromycin.]
[C05CA01, rutin, The metabolism of Zopiclone can be decreased when combined with Rutin.]
[A07EC01, sulfasalazine, The risk or severity of methemoglobinemia can be increased when Sulfasalazine is combined with Zopiclone.]
[S01BC08, salicylic acid, The metabolism of Zopiclone can be decreased when combined with Salicylic acid.]
[S01FA02, scopolamine, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Scopolamine.]
[N05CA06, secobarbital, The metabolism of Zopiclone can be increased when combined with Secobarbital.]
[N04BD01, selegiline, The risk or severity of adverse effects can be increased when Selegiline is combined with Zopiclone.]
[H01CB01, somatostatin, The metabolism of Zopiclone can be decreased when combined with Somatostatin.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Zopiclone.]
[C03DA01, spironolactone, The metabolism of Zopiclone can be decreased when combined with Spironolactone.]
[N03AG01, valproic acid, The metabolism of Zopiclone can be decreased when combined with Valproic acid.]
[C01DA14, isosorbide mononitrate, The risk or severity of methemoglobinemia can be increased when Isosorbide mononitrate is combined with Zopiclone.]
[H02CA04, levoketoconazole, The metabolism of Zopiclone can be decreased when combined with Levoketoconazole.]
[R03BB01, ipratropium bromide, Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Ipratropium.]
